Evidence map›Paper›PMID 42626643›Full record

ArticleEuropean heart journal. Digital health2026

Development and validation of an artificial intelligence-based tool to detect subclinical atheroesclerosis using non-mydriatic retinal funduscopic images: the Aitheroscope project.

Juan Torres-Macho, María Ángeles Sánchez-Uriz, Vyara Hrystova, Jesús Prada-Alonso, Jose Manuel López-Aragonés, Nuria Muñoz-Rivas, Anabel Franco-Moreno, Eva Moya-Mateo, María Pilar Ferrera-Ahijado, Eva María Duro-Perales and 11 more

Abstract read
In one paragraph

Article in European heart journal. Digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Juan Torres-MachoInternal Medicine Department, Infanta Leonor University Hospital, Av Gran vía del este 80, Madrid 28031, Spain.ORCID https://orcid.org/0000-0002-8860-6837
María Ángeles Sánchez-UrizOccupational Health Department, Infanta Leonor University Hospital, Madrid, Spain.
Vyara HrystovaOphthalmology Department, Infanta Leonor University Hospital, Madrid, Spain.
Jesús Prada-AlonsoHorus-ML, Alcalá Street 268, Madrid 28027, Spain.
Jose Manuel López-AragonésOccupational Health Department, Infanta Leonor University Hospital, Madrid, Spain.ORCID https://orcid.org/0009-0005-5004-4436
Nuria Muñoz-RivasDepartment of Medicine, Complutense University, Madrid.
Anabel Franco-MorenoDepartment of Medicine, Complutense University, Madrid.
Eva Moya-MateoDepartment of Medicine, Complutense University, Madrid.
María Pilar Ferrera-AhijadoOccupational Health Department, Infanta Leonor University Hospital, Madrid, Spain.
Eva María Duro-PeralesOccupational Health Department, Infanta Leonor University Hospital, Madrid, Spain.
María Antón-VallejoOccupational Health Department, Infanta Leonor University Hospital, Madrid, Spain.
Montserrat Saiz-GonzálezOccupational Health Department, Infanta Leonor University Hospital, Madrid, Spain.
Alberto Diez-GarcíaOccupational Health Department, Infanta Leonor University Hospital, Madrid, Spain.
Celeste Marina-VerdeOphthalmology Department, Infanta Leonor University Hospital, Madrid, Spain.
Andrés Rosa-LópezOphthalmology Department, Infanta Leonor University Hospital, Madrid, Spain.
Inmaculada Fernández-SotilloOphthalmology Department, Infanta Leonor University Hospital, Madrid, Spain.
Carolina Espejo-PaeresHorus-ML, Alcalá Street 268, Madrid 28027, Spain.
Miguel Bravo-PrietoHorus-ML, Alcalá Street 268, Madrid 28027, Spain.
Javier Corrochano Del PinoHorus-ML, Alcalá Street 268, Madrid 28027, Spain.
Carmen Pantoja-ZarzaHospital Manager, Infanta Leonor University Hospital, Madrid, Spain.
María José Crespo-CarballésDepartment of Medicine, Complutense University, Madrid.ORCID https://orcid.org/0000-0001-5743-0499

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims: Current cardiovascular risk scores may underestimate the risk of future cardiovascular events, particularly in younger individuals with prolonged exposure to risk factors. In contrast, imaging-based detection of subclinical atherosclerosis provides a more accurate assessment of cardiovascular risk by identifying established vascular disease. We aimed to develop and prospectively validate an artificial intelligence-based tool using retinal fundus images to detect ultrasound-confirmed subclinical atherosclerosis. Methods and results: In this prospective observational study, 931 participants (mean age 52.6 years; 70.2% women) without prior cardiovascular disease underwent standardized clinical evaluation, non-mydriatic retinal imaging, and carotid and femoral ultrasound to detect subclinical atherosclerosis. A multimodal AI model integrating deep learning from retinal images with radiomic and clinical data was developed in a derivation cohort ( Conclusion: AI-based retinal image analysis enables non-invasive detection of systemic subclinical atherosclerosis. This scalable approach may enhance early identification of high cardiovascular-risk patients, particularly in populations in whom risk is underestimated.

Indexed as

Artificial intelligenceCardiovascular riskMachine learningNon-mydriatic retinographyRetinal fundus imagingScreeningSubclinical atherosclerosis

Identifiers

PMID42626643
PMCPMC13492337

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.